SANOFI-AVENTIS (EPA:SAN)

PRESS RELEASE

published on 06/26/2024 at 23:30, 1 year 9 months ago

Press Release: Dupixent positive phase 3 data in children one to 11 years of age with eosinophilic esophagitis published in NEJM
Positive phase 3 data of Dupixent in children aged 1-11 with eosinophilic esophagitis published in NEJM highlights significant histologic remission achieved and sustained improvements, potentially changing standard of care

Children Phase 3 Study Dupixent Eosinophilic Esophagitis NEJM Publication
BRIEF

published on 06/25/2024 at 19:37, 1 year 9 months ago

Sanofi Releases Q2 2024 Aide-Mémoire to Assist Financial Modelling

Financial Results Investors Q2 2024 Sanofi Aide-mémoire
PRESS RELEASE

published on 06/25/2024 at 19:32, 1 year 9 months ago

Press Release: Availability of the Q2 2024 Aide-mémoire
Sanofi announces availability of Q2 2024 Aide-mémoire, assisting in financial modeling of quarterly results. Document includes non-comparable items, exclusivity losses, and more

Q2 2024 Quarterly Results Sanofi Financial Modeling Aide-mémoire
BRIEF

published on 06/21/2024 at 09:35, 1 year 9 months ago

Sanofi appoints Audrey Duval Derveloy Group Corporate Affairs Director

Executive Committee Social Responsibility Nomination Sanofi Audrey Duval Derveloy
PRESS RELEASE

published on 06/21/2024 at 09:30, 1 year 9 months ago

Press Release: Audrey Duval Derveloy appointed Global Head of Corporate Affairs, member of Sanofi’s Executive Committee
Audrey Duval Derveloy appointed Global Head of Corporate Affairs at Sanofi, joining Executive Committee. Responsible for stakeholder engagement and CSR strategy globally

Executive Committee Sanofi Audrey Duval Derveloy Corporate Affairs Global Head
BRIEF

published on 06/21/2024 at 07:05, 1 year 9 months ago

Sanofi strengthens its leadership in the treatment of hemophilia

Sanofi Fitusiran ISTH Haemophilia ALTUVIIO
PRESS RELEASE

published on 06/21/2024 at 07:00, 1 year 9 months ago

Press Release: ISTH: Sanofi advances leadership in hemophilia with new data for ALTUVIIIO and fitusiran
Sanofi presents new data on ALTUVIIIO and fitusiran at ISTH Congress, showcasing potential first- and best-in-class treatments for hemophilia. Fitusiran NDA under FDA review with PDUFA date of March 28, 2025

Sanofi ALTUVIIIO Fitusiran Hemophilia ISTH Congress
BRIEF

published on 06/12/2024 at 20:24, 1 year 9 months ago

Sanofi: Information on voting rights and shares - May 2024

Voting Rights Investors Actions Sanofi May 2024
PRESS RELEASE

published on 06/12/2024 at 20:19, 1 year 9 months ago

Sanofi: Information concerning the total number of voting rights and shares – May 2024
Sanofi discloses total number of voting rights and shares as per French commercial code and stock market authority regulations. Details available on Sanofi's website

Voting Rights French Commercial Code Shares Sanofi Stock Market Authority
BRIEF

published on 06/03/2024 at 22:20, 1 year 9 months ago

Phase III study: Sarclisa improves progression-free survival of patients with multiple myeloma

Multiple Myeloma Sarclisa ASCO Phase III Study Progression-free Survival

Published on 03/26/2026 at 23:00, 9 hours 1 minute ago

FutureGen Industries Announces Closing of Debt Settlement
Published on 03/26/2026 at 22:05, 9 hours 56 minutes ago

BlackBerry to Announce Fourth Quarter and Fiscal Year 2026 Results on April 9, 2026
Published on 03/26/2026 at 22:00, 10 hours 1 minute ago

Clean Air Metals Receives Provincial Funding and Provides Update on the Thunder Bay North Project
Published on 03/26/2026 at 22:00, 10 hours 1 minute ago

Green Bridge Metals Reports Visible Copper Sulfide Mineralization in Initial 2026 Titac Drilling, Duluth Complex Minnesota
Published on 03/26/2026 at 21:00, 11 hours 1 minute ago

Worksport Reports Record FY 2025 Results, Issues $35M–$42M 2026 Revenue Guidance; Targets Initial Cash Flow Positivity

View all ACCESSWIRE

Published on 03/27/2026 at 07:45, 16 minutes ago

Pyrum Innovations AG publishes preliminary results for financial year 2025
Published on 03/27/2026 at 07:30, 31 minutes ago

DKSH Performance Materials Acquires AIC Ingredients, a Leading Customized Food Solutions Manufacturer in Malaysia
Published on 03/27/2026 at 07:30, 31 minutes ago

Haier Celebrates Excellence in Paris With New Smart Home Portfolio
Published on 03/27/2026 at 07:00, 1 hour 1 minute ago

Edisun Power Europe AG: Demanding year reinforces the urgency of advancing the ‘Renewables to AI’ strategy
Published on 03/27/2026 at 07:00, 1 hour 1 minute ago

AEVIS VICTORIA SA (AEVS.SW) – Swiss Medical Network Holding SA publishes 2025 results and accelerates the expansion of its integrated care model

View all EQS

Published on 03/26/2026 at 18:17, 13 hours 44 minutes ago

Eiffage strengthens its position in Getlink capital
Published on 03/26/2026 at 17:45, 14 hours 16 minutes ago

Cegedim: profitability continues to improve
Published on 03/26/2026 at 08:57, 23 hours 3 minutes ago

Edenred statement
Published on 03/26/2026 at 07:30, 1 day ago

BIOPHYTIS-LYNXKITE ALLIANCE INVITED TO NVIDIA CONFERENCE: UNLEASHING AI TO REVOLUTIONIZE LONGEVITY
Published on 03/25/2026 at 18:53, 1 day 13 hours ago

LNA SANTE : 2025 Annual Results

View all LES ECHOS COMFI WIRE

News